Cargando…
Purification of Human CD34(+)CD90(+) HSCs Reduces Target Cell Population and Improves Lentiviral Transduction for Gene Therapy
Hematopoietic stem cell (HSC) gene therapy has the potential to cure many genetic, malignant, and infectious diseases. We have shown in a nonhuman primate gene therapy and transplantation model that the CD34(+)CD90(+) cell fraction was exclusively responsible for multilineage engraftment and hematop...
Autores principales: | Radtke, Stefan, Pande, Dnyanada, Cui, Margaret, Perez, Anai M., Chan, Yan-Yi, Enstrom, Mark, Schmuck, Stefanie, Berger, Andrew, Eunson, Tom, Adair, Jennifer E., Kiem, Hans-Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424231/ https://www.ncbi.nlm.nih.gov/pubmed/32802914 http://dx.doi.org/10.1016/j.omtm.2020.07.010 |
Ejemplares similares
-
Safe and efficient lentiviral vector integration with HSC-targeted gene therapy
por: Radtke, Stefan, et al.
Publicado: (2023) -
Isolation of a Highly Purified HSC-enriched CD34(+)CD90(+)CD45RA(−) Cell Subset for Allogeneic Transplantation in the Nonhuman Primate Large-animal Model
por: Radtke, Stefan, et al.
Publicado: (2020) -
Lentiviral Transduction of CD34(+) Cells Induces Genome-Wide Epigenetic Modifications
por: Yamagata, Yoshiaki, et al.
Publicado: (2012) -
Lentiviral Based Gene Transduction and Promoter Studies in Human Hematopoietic Stem Cells (hHSCs)
por: Varma, N, et al.
Publicado: (2011) -
Decitabine Suspends Human CD34(+) Cell Differentiation and Proliferation during Lentiviral Transduction
por: Uchida, Naoya, et al.
Publicado: (2014)